Author:
El Kassas Mohamed,El Sheemy Reem,Alboraie Mohamed,El Badry Mohamed,Wifi Mohamed Naguib,Youssef Naglaa,Ezzat Sameera,Tahoon Marwa,Abdelsalam Lobna,Abdelhakam Sara M.,Ali-Eldin Zainab
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. European Centre for Disease Prevention and Control, Hepatitis C—Annual Epidemiological Report for 2015 Stockholm: 2017.
https://ecdc.europa.eu/en/publications-data/hepatitis-c-annual-epidemiological-report-2015
. Accessed 12 Jan 2018
2. Ministry of Health and Population [Egypt], El-Zanaty and Associates [Egypt], and ICF International (2015) Egypt Health Issues Survey 2015. Ministry of Health and Population and ICF International, Cairo.
https://dhsprogram.com/pubs/pdf/FR313/FR313.pdf
. Accessed 15 Jan 2018
3. Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, Waked I, Alavian SM, Lee MH, Negro F, Abaalkhail F (2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2(3):161–176
4. Esmat G, El Kassas M, Hassany M, Gamil ME, El Raziky M (2013) How to optimize HCV therapy in genotype 4 patients. Liver Int 33:41–45
5. Esmat G, El Kassas M, Hassany M, Gamil M, El Raziky M (2014) Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs PEG-IFN alfa 2b; the debate continues. Liver Int 34:24–28
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献